Author: The Editor

Post
In conversation with ICBC founder Alex Rogers

In conversation with ICBC founder Alex Rogers

The ICBC is the largest B2B international cannabis conference series Europe, so ahead of its upcoming Barcelona incarnation we spoke to its founder Alex Rogers about what’s driven the ICBC’s success so far and what to expect in Spain. For Alex, part of the reason the ICBC got so large is fortunate timing. “Medical cannabis...

Post
A Lot of CBD gets you a little Stoned

A Lot of CBD gets you a little Stoned

Cannabidiol or CBD has been getting a lot of press lately. This substance from the cannabis plant is generally regarded as non-intoxicating, with the feeling of being high associated with consumption of tetrahydrocannabinol aka THC.

Post
Is Cannabis ‘driving us mad?’ Or is madness driving us to Cannabis?

Is Cannabis ‘driving us mad?’ Or is madness driving us to Cannabis?

Today’s article in the Spectator may have read very differently if the Author had heard the President’s Lecture at the Royal College of Psychiatrists (RCP) On Wednesday, Professor David Nutt took on one of the greatest challenges in drug reform advocacy, explaining to a room full of psychiatrists that a regulated cannabis market would be...

Post
Canopy Growth enters the UK

Canopy Growth enters the UK

Source: Canopy Growth Spectrum Biomedical UK (Spectrum UK) is a newly formed company focused on providing access of cannabis-based medicinal products to UK patients with severe clinical unmet need. The joint venture between Canopy Growth Corporation (Canopy Growth) (TSX: WEED) (NYSE: CGC) and Beckley Canopy Therapeutics (Beckley Canopy) will be the exclusive distributor of Spectrum...